Article Information
History
- January 6, 2022.
Article Versions
- Version 1 (January 5, 2022 - 23:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Fanglei Zuo1,*,
- Hassan Abolhassani1,*,
- Likun Du1,*,
- Antonio Piralla2,*,
- Federico Bertoglio3,
- Leire de Campos-Mata1,
- Hui Wan1,
- Maren Schubert3,
- Yating Wang1,
- Rui Sun1,
- Irene Cassaniti2,
- Stelios Vlachiotis1,
- Makiko Kumagai-Braesch4,
- Juni Andréll5,
- Zhaoxia Zhang6,
- Yintong Xue7,
- Esther Veronika Wenzel3,8,
- Luigi Calzolai9,
- Luca Varani10,
- Nima Rezaei11,
- Zahra Chavoshzadeh12,
- Fausto Baldanti2,13,#,
- Michael Hust3,#,
- Lennart Hammarström1,#,
- Harold Marcotte1,# and
- Qiang Pan-Hammarström1,#,†
- 1Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
- 2Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
- 3Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics; Department of Biotechnology, Braunschweig, Germany
- 4Division of Transplantation Surgery, CLINTEC, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden
- 5Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
- 6Department of Aging Neurology orthopedics, Karolinska University Hospital Huddinge, Stockholm, Sweden
- 7Department of Immunology, Peking University Health Science Center, Beijing, China
- 8Abcalis GmbH, Science Campus Braunschweig-Süd, Inhoffenstr. 7, 38124 Braunschweig, Germany
- 9European Commission, Joint Research Centre, Ispra, Italy
- 10Institute for Research in Biomedicine, Università della Svizzera italiana (USI), Bellinzona, Switzerland
- 11Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
- 12Pediatric Infections Research Center, Mofid Children’s Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 13Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy
- ↵†Corresponding author; email: qiang.pan-hammarstrom{at}ki.se
↵* These authors contributed equally
Posted January 06, 2022.
Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant
